Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow-to-Debt Ratio
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of CN¥318.80 Million could theoretically repay 0% of its total liabilities (CN¥1.60 Billion) in one year. See financial flexibility index of Beijing Tiantan Biological Products Corp to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Tiantan Biological Products Corp Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Beijing Tiantan Biological Products Corp.
Annual Cash Flow-to-Debt Ratio for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year debt coverage analysis for Beijing Tiantan Biological Products Corp Ltd. Check how high is Beijing Tiantan Biological Products Corp's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.61x | CN¥819.78 Million | CN¥1.34 Billion | ▼ -63.3% |
| 2023 | 1.67x | CN¥2.39 Billion | CN¥1.43 Billion | ▲ +134.9% |
| 2022 | 0.71x | CN¥1.13 Billion | CN¥1.58 Billion | ▼ -5.0% |
| 2021 | 0.75x | CN¥980.35 Million | CN¥1.31 Billion | ▲ +60.9% |
| 2020 | 0.46x | CN¥702.11 Million | CN¥1.51 Billion | ▼ -17.7% |
| 2019 | 0.57x | CN¥642.47 Million | CN¥1.14 Billion | ▼ -40.0% |
| 2018 | 0.94x | CN¥677.92 Million | CN¥720.19 Million | ▲ +107.5% |
| 2017 | 0.45x | CN¥218.39 Million | CN¥481.46 Million | ▲ +253.9% |
| 2016 | 0.13x | CN¥428.37 Million | CN¥3.34 Billion | ▼ -8.0% |
| 2015 | 0.14x | CN¥473.26 Million | CN¥3.40 Billion | ▲ +10.7% |
| 2014 | 0.13x | CN¥477.95 Million | CN¥3.80 Billion | ▼ -23.2% |
| 2013 | 0.16x | CN¥566.43 Million | CN¥3.46 Billion | ▲ +14.8% |
| 2012 | 0.14x | CN¥432.00 Million | CN¥3.03 Billion | ▼ -28.2% |
| 2011 | 0.20x | CN¥353.15 Million | CN¥1.78 Billion | ▲ +40.3% |
| 2010 | 0.14x | CN¥184.85 Million | CN¥1.31 Billion | ▼ -61.7% |
| 2009 | 0.37x | CN¥448.23 Million | CN¥1.21 Billion | ▼ -41.2% |
| 2008 | 0.63x | CN¥276.39 Million | CN¥439.35 Million | ▲ +51.3% |
| 2007 | 0.42x | CN¥153.55 Million | CN¥369.34 Million | ▼ -4.1% |
| 2006 | 0.43x | CN¥154.36 Million | CN¥356.20 Million | ▼ -40.9% |
| 2005 | 0.73x | CN¥131.69 Million | CN¥179.67 Million | ▼ -16.3% |
| 2004 | 0.88x | CN¥110.11 Million | CN¥125.70 Million | ▲ +121.7% |
| 2003 | 0.40x | CN¥62.93 Million | CN¥159.24 Million | ▲ +1.0% |
| 2002 | 0.39x | CN¥84.38 Million | CN¥215.73 Million | ▲ +46.1% |
| 2001 | 0.27x | CN¥46.49 Million | CN¥173.64 Million | ▼ -6.8% |
| 2000 | 0.29x | CN¥47.90 Million | CN¥166.77 Million | ▲ +7.8% |
| 1999 | 0.27x | CN¥42.58 Million | CN¥159.88 Million | ▲ +26.4% |
| 1998 | 0.21x | CN¥23.71 Million | CN¥112.54 Million | — |